CDX2 gene expression and clinical significance in children with acute lymphoblastic leukemia

Dongning Wang,Yi He,Xudong Li,Yuan Hu,Wenwen Wang,Renwei Huang
2014-01-01
Abstract:This research was designed to investigate CDX2 gene expression and clinical significance in children with acute lymphoblastic leukemia. Marrow samples were taken from 160 CDX Children with newly diagnosed ALL. , Multiplex RT-PCR was used to detect common ALL fusion gene, while regular RT-PCR was used to detect CDX2 gene. Comparative semi-quantitative method was used to analyze the relative expression levels of CDX2 in each group and their relationship with the treatment efficacy. Among those 160 patients, 10 were BCR / ABL-positive, 8 were E2A / PBX1 positive, 26 were TEL / AML1-positive, 8 were SIL / TAL1 positive, and 42 were MLL abnormalities (including translocations and repeat). 130 out of those 160 patients showed CDX2 positive (81.3%). The control group showed CDX2 negative. CDX2 expressions in B-ALL and T-ALL groups were 0.4675 ± 0.2372 and 0.4563 ± 0.2031, respectively. The expression difference between these two groups was not statistically significant (P> 0.05). There were significant differences (P <0.05) for each positive group CDX2 fusion gene expression levels, wherein the fusion gene negative group was the highest (0.4935 ± 0.2450). After the chemotherapy, 119 cases of 130 CDX2 gene-positive patients reached CR (91.7%), while all 30 cases of CDX2 gene-negative patients reached CR (100%). The treatment difference was not statistically significant between these two groups. However, the CDX2 expressions were statistically different between the group of 119 CDX2-positive patients who achieved CR after chemotherapy and the 11 CDX2-positive patients who didn’t reach CR after chemotherapy. CONCLUSIONS: CDX2 expression was common among ALL children. CDX2 expression was high on those child patients with common fusion gene negative. CDX2 expression levels were highly associated with the chemotherapy efficacy and can be used as an indicator to monitor MRD.
What problem does this paper attempt to address?